Telesis Bio Inc.

NASDAQ: TBIO
$0.90
+$0.00 (+0.0%)
Closing Price on November 21, 2024

TBIO Stock Chart and Intraday Price

TBIO Stock Data

Asset Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry LABORATORY ANALYTICAL INSTRUMENTS
Address 9535 WAPLES STREET, SUITE 100, SAN DIEGO, CA, US
Fiscal Year End December
Latest Quarter 2023-12-31
Market Cap 13.63M USD
Shares Outstanding 29,983,700
Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutic company, develops drugs to treat diseases caused by protein or gene dysfunction. The company is headquartered in Lexington, Massachusetts.

TBIO Articles

Thursday's top analyst upgrades and downgrades included Agilent Technologies, Carnival, Clorox, Darden Restaurants, Pinduoduo, QuantumScape, Royal Dutch Shell and Williams-Sonoma.
Monday's top analyst upgrades and downgrades included American Express, AT&T, CRISPR Therapeutics, DocuSign, ONEOK, Regeneron Pharmaceuticals, Shopify and Tesla.
Sanofi and Translate Bio are making waves in the fight against the novel coronavirus as the two have agreed to expand their existing 2018 collaboration and license agreement